
Uppsala Reports editor
@UMCGlobalSafety
Research / 04 June 2025
Spontaneous adverse event reports pose significant challenges to pharmacovigilance scientists. How may we turn them into opportunities that benefit our pharmacovigilance systems?
Spontaneous adverse event reporting keeps the wheel of pharmacovigilance turning, but poses significant challenges that impact its efficacy. For one, only a fraction of adverse events are reported, and what is reported is of poor quality.
In this episode of Drug Safety Matters, Fredrik Brounéus is joined by Henry Zakumumpa, a researcher at Makerere University in Kampala, Uganda whose qualitative study on factors affecting adverse event reporting in the country has uncovered some surprising findings.
AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.
22 October 2024
The READUS-PV statement is the first-ever guide for reports of disproportionality analyses that are replicable, reliable, and reproducible.
07 October 2024
To tackle the lack of medicine and vaccine safety data for pregnant people, UMC has developed an algorithm to more easily identify pregnancy-related reports in VigiBase.
21 January 2025